Saving Robert's Life

2016-09-02_8-49-54

ROBERT HAD MONTHS TO LIVE

Presenting with a CD4 count of only 21, doctors gave Robert months to live. Weighing 98 pounds, his HIV had progressed to Stage 3 AIDS.

Though he wanted to get better, he had to make decisions on which medications to buy based on what he could afford. Complicating Robert’s case was the fact that he had developed coronary artery disease and needed a bypass. However, surgeons could not consider him a candidate for the procedure until his HIV viral load became undetectable.

This was Robert’s condition when he enrolled with Curant Health in January, 2014.

CURANT HEALTH AND VIRGINIA COMMONWEALTH UNIVERSITY PARTNER TO GET ROBERT ON TRACK

Curant Health, along with Robert’s team of clinicians at Virginia Commonwealth University worked together to eliminate the roadblocks to compliance that were killing Robert.

As part of his personalized medication program, Robert’s medications were aggregated and sent in bubble packaging, making it much easier to adhere to his prescribed therapy. Robert’s patient care coordinator spoke to him every month to ensure he remained adherent. She was his friendly reminder, a voice of compassion and knowledge that served equal parts encouragement and information source.

Curant removed financial roadblocks. Even though he was covered by insurance, Robert faced medication copays totaling $700 per month. Curant notified VCU that its 340B funds could be used pay Robert’s co-pays. For the first time, Robert had full access to all of the medication he needed at the same time.

HOW IS ROBERT TODAY?

With medication costs covered, adherence packaging and monthly check-ins, Robert began a remarkable recovery. By July, his CD4 count rose to 96. More importantly, his viral load became undetectable, making him a candidate to receive the needed bypass surgery. Robert is currently
preparing to develop a plan to treat his coronary artery disease and he weighs a healthy 188 pounds. Assuming his bypass surgery is successful, Robert is likely to enjoy a normal lifespan.

66% of patients who were not virally suppressed at program enrollment with Curant Health were virally suppressed at follow up.

In a study with 130 HIV patients, 87% of patients were determined to be adherent to antiretroviral therapy (ART)

Patients in this study demonstrated a 28% increase in medication adherence after receiving personalized medication management services from Curant Health; annual cost of care was reduced by $3,000 per patient.

Want to learn more about Curant Health's success with Virginia Commonwealth University patients?

Kristin Lindsey
Sr. Marketing Director
klindsey@curanthealth.com
866-437-8040 ext. 253

curanthealth.com/programs/hiv-treatment

 
EmailEmailEmailEmail
Menu Title